"10.1371_journal.pone.0128741","plos one","2015-06-15T00:00:00Z","Isabelle Mah√©; Raluca Sterpu; Laurent Bertoletti; Luciano L√≥pez-Jim√©nez; Meritxell Mellado Joan; Javier Trujillo-Santos; Aitor Ballaz; Luis Manuel Hern√°ndez Blasco; Pablo Javier Marchena; Manuel Monreal; RIETE investigators","Department of Internal Medicine, H√¥pital Louis Mourier, Colombes (APHP), University Paris 7, EA REMES 7334, Universit√© Paris Diderot, Sorbonne Paris Cit√©, France; Department of Internal Medicine, H√¥pital Louis Mourier, Colombes, (APHP), University Paris 7, Paris, France; Department of Vascular and Therapeutic Medicine, CHU Saint-Etienne, H√¥pital Nord, Saint-Etienne, France; Department of Internal Medicine, Hospital Provincial Reina Sof√≠a, C√≥rdoba, Spain; Department of Angiology and Vascular Surgery, Hospital del Mar, Barcelona, Spain; Department of Internal Medicine, Complejo Hospitalario Universitario de Cartagena, Murcia, Spain; Department of Pneumonology, Hospital de Galdakao, Vizcaya, Spain; Department of Pneumonology, Hospital General Universitario de Alicante, Alicante, Spain; Department of Internal Medicine, Parc Sanitari Sant Joan de Deu-Hospital General, Barcelona, Spain; Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain","Conceived and designed the experiments: IM RS MM. Performed the experiments: IM RS LB LLJ MMJ JTS AB LMHB PJM MM. Analyzed the data: IM RS MM JTS PM. Contributed reagents/materials/analysis tools: IM RS LB LLJ MMJ JTS AB LMHB PJM MM. Wrote the paper: IM RS LB LLJ MMJ JTS AB LMHB PJM MM. Study concept and design: IM RS MM. Acquisition of data: LB MMJ AB LMHB MM. Analysis and interpretation of data: IM LB JTS PJM MM. Drafting of the manuscript: IM RS MM. Critical revision of the manuscript for important intellectual content: LB JTS. Final approval of the article: IM RS LB LLJ MMJ JTS AB LMHB PJM MM. Had full access to all the data in the study and take responsibility for the integrity of the data: IM MM.","The RIETE Registry was supported with an unrestricted educational grant from Sanofi Spain and Bayer Pharma AG. Bayer Pharma AG‚Äôs support was limited to the part of RIETE outside Spain, which accounts for a 20.05% of the total patients included in the RIETE Registry. The authors have nothing to disclose. The authors have declared that no competing interests exist.","2015","06","Isabelle Mah√©","IM√",11,FALSE,3,10,5,10,TRUE,TRUE,TRUE,1,"11",TRUE
